Concepedia

Jayne Cartmell

JC

22

Publications

1.7K

Citations

19

H-Index

1992

Active since

Affiliations

Eli Lilly (United States)(Current)

Roche (Switzerland)

Queen's Medical Centre

University of Nottingham

Abbott (United States)

Jayne Cartmell is an author at Eli Lilly (United States) specializing in medicine, neuropharmacology, and neuroscience.

Top concepts

Publications per year

1992–2004

22

Publications

22

A-317491, a novel potent and selective non-nucleotide antagonist of P2X <sub>3</sub> and P2X <sub>2/3</sub> receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 458 citations · Full text

The Metabotropic Glutamate 2/3 Receptor Agonists LY354740 and LY379268 Selectively Attenuate Phencyclidine versus d-Amphetamine Motor Behaviors in Rats

Jayne Cartmell, James A. Monn, Darryle D. Schoepp · Journal of Pharmacology and Experimental Therapeutics · 1999 · 268 citations

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

Jayne Cartmell, James A. Monn, Darryle D. Schoepp · Psychopharmacology · 2000 · 117 citations

, , +10

TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics

Prisca Honoré, Joseph P. Mikusa, Bruce R. Bianchi et al. · Pain · 2002 · 110 citations

In Vitro Binding Characteristics of a New Selective Group II Metabotropic Glutamate Receptor Radioligand, [3H]LY354740, in Rat Brain

Hervé Schaffhauser, John Richards, Jayne Cartmell et al. · Molecular Pharmacology · 1998 · 95 citations · Full text

Rows per page

1–5 of 22